Stock METABOLIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Metabolix, Inc. Nasdaq

Equities

US5910188821

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Metabolix, Inc.
05-20 Yield10 Bioscience, Inc.(OTCPK:YTEN) dropped from S&P TMI Index CI
05-15 Earnings Flash (YTEN) YIELD10 BIOSCIENCE Posts Q1 Revenue $300,000 MT

Business Summary

Yield10 Bioscience, Inc., formerly Metabolix, Inc., is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, the Company is advancing several yield traits it has developed in crops, such as Camelina, canola, soybean and corn. The Company concentrates on technologies that enables it to improve carbon dioxide fixation efficiency in photosynthesis and its direction to and conversion into plant matter. The Company has an additional agricultural science facility with greenhouses in Saskatoon, Saskatchewan, Canada.

Sales per Business

USD in Million2022Weight2023Weight Delta
Specialty Oils and Niche Crops
100.0 %
0 100.0 % 0 100.0 % -86.67%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
0 100.0 % 0 100.0 % -86.67%

Managers

Managers TitleAgeSince
Oliver Peoples FOU
 Founder 66 31/05/92
Charles Haaser DFI
 Director of Finance/CFO 68 31/12/07
Kristi Snell CTO
 Chief Tech/Sci/R&D Officer 56 31/12/96
Lynne Brum IRC
 Investor Relations Contact 60 31/10/11

Members of the board

Members of the board TitleAgeSince
Robert van Nostrand CHM
 Chairman 67 30/09/06
Richard Hamilton BRD
 Director/Board Member 61 01/03/17
Oliver Peoples FOU
 Founder 66 31/05/92
Anthony Sinskey FOU
 Founder 83 31/05/92
Sherri Brown BRD
 Director/Board Member 63 10/02/20
Willie Loh BRD
 Director/Board Member 69 03/10/22

Shareholders

NameEquities%Valuation
Jack Schuler
10.16 %
1,564,920 10.16 % 374 016 $
Armistice Capital LLC
6.011 %
925,860 6.011 % 221 281 $
Cannell & Spears LLC
1.611 %
248,113 1.611 % 59 299 $
Cannell & Co.
1.611 %
248,113 1.611 % 59 299 $
Charles Haaser
0.9146 %
140,861 0.9146 % 33 666 $
G1 Execution Services LLC
0.5089 %
78,385 0.5089 % 18 734 $
Oliver Peoples
0.4816 %
74,181 0.4816 % 17 729 $
Richard Hamilton
0.4714 %
72,598 0.4714 % 17 351 $
Anthony Sinskey
0.4173 %
64,274 0.4173 % 15 361 $
Geode Capital Management LLC
0.4058 %
62,497 0.4058 % 14 937 $

Company contact information

Yield10 Bioscience, Inc.

19 Presidential Way

01801-1184, Woburn

+(617) 583-1700

http://www.yield10bio.com
address Metabolix, Inc.

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per region

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MODERNA, INC. Stock Moderna, Inc.
+67.53% 63.85B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.77% 41.83B
LONZA GROUP AG Stock Lonza Group AG
+45.66% 40.65B
CELLTRION, INC. Stock Celltrion, Inc.
-10.72% 27.12B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+13.30% 26.52B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-22.79% 18.69B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+4.70% 12.73B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+24.10% 12.11B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.41% 12.07B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. YTEN Stock
  4. Stock
  5. Company Metabolix, Inc.